Dr. Moshe Faynsod, MD

Dr. Faynsod practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Faynsod's NPI, 1851361000, was assigned on January 23, 2006. Dr. Faynsod graduated from University Of Michigan Medical School in 1996. Dr. Faynsod's California license number on file is A65167.

Dr. Faynsod's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (626) 256-4673.

Dr. Faynsod's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Dr. Faynsod is also affiliated with Torrance Memorial Medical Center. The medical group on file is City of Hope. Dmand AI also links Dr. Faynsod to 2 more hospitals, 1 physician office, 1 group practice or clinic and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Faynsod practices, 6 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Faynsod's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Faynsod is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Faynsod's licenses on file in 2 states: California and New York.

Dmand AI lists abdominal hernia repair surgery, cancerous skin growth removal, gallbladder removal, groin hernia surgery, mastectomy and thyroid surgery among the conditions Dr. Faynsod treats.

CMS data shows 402 Medicare services from Dr. Faynsod across 6 procedure codes in 2024, for 244 Medicare patients. Medicare paid $72,271 for them.

CMS counts 244 Medicare patients who saw Dr. Faynsod in 2024. The largest group is 65 to 74, with 106 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Faynsod's median patient age at 70, with 63% women.

In 2024, Dr. Faynsod wrote 127 Medicare Part D claims for 102 patients. 100% of them were for generic drugs. CMS names the drug for 100 of them, across 1 drug with 11 or more claims each, at $592 in total drug cost. In 2023, CMS named 80 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Faynsod for performance year 2024, reported as part of a group. Dr. Faynsod accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 64 procedures of melanoma (skin cancer) excision by Dr. Faynsod, more than 89% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Faynsod in 2005. The most frequent topics are Chemotherapy, Adjuvant. Dr. Faynsod's most frequent co-authors are Tracey Dianne Arnell, MD, Michael J Stamos, MD and Lucille Leong, MD.

CMS Open Payments shows 48 general payments to Dr. Faynsod from 12 drug and device companies from 2016 to 2022. Education make up the largest share, 86% of the total. Intuitive Surgical, Inc. paid the most, $25,265.

Dmand AI lists 1 award for Dr. Faynsod.

Dr. Faynsod graduated from University Of Michigan Medical School in 1996. Dr. Faynsod is a member of ACS.

Dr. Faynsod is in network with 16 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.